The individuals recalled were previously identified by our group11 to be at high risk of cholestatic liver disease based on their genotype (rare heterozygous loss of function (LoF) variants in ABCB4 or ABCB11) or phenotype (ICP). Here, ABCB11 is linked to Cholestatic liver disease.